Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingredion (INGR) Cash & Equivalents (2016 - 2025)

Ingredion (INGR) has disclosed Cash & Equivalents for 17 consecutive years, with $915.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 4.33% year-over-year to $915.0 million, compared with a TTM value of $915.0 million through Sep 2025, up 4.33%, and an annual FY2024 reading of $997.0 million, up 148.63% over the prior year.
  • Cash & Equivalents was $915.0 million for Q3 2025 at Ingredion, up from $861.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $997.0 million in Q4 2024 and bottomed at $236.0 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $526.4 million, with a median of $436.0 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents plummeted 50.68% in 2021, then skyrocketed 161.79% in 2024.
  • Year by year, Cash & Equivalents stood at $328.0 million in 2021, then dropped by 28.05% to $236.0 million in 2022, then surged by 69.92% to $401.0 million in 2023, then skyrocketed by 148.63% to $997.0 million in 2024, then fell by 8.22% to $915.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for INGR at $915.0 million in Q3 2025, $861.0 million in Q2 2025, and $837.0 million in Q1 2025.